AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2018
Aug 9, 2018
30583_dirs_2018-08-09_850a6586-18ec-415d-8e0b-69efa7ec10f4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2018-08-07
Reporting Person: BAFFI ROBERT (EVP, Technical Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-07 | Common Stock | S | 5173 | $105.00 | Disposed | 71882 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 83276 | Direct |
Footnotes
F1: Trade made pursuant to a 10b5-1 plan executed on September 12, 2017.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19